- Home
- ADN vs TRAW Comparison
ADN vs TRAW Comparison
Compare ADN & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- TRAW
- Stock Information
- Founded
- ADN 2006
- TRAW 1998
- Country
- ADN United States
- TRAW United States
- Employees
- ADN N/A
- TRAW N/A
- Industry
- ADN Power Generation
- TRAW
- Sector
- ADN Utilities
- TRAW
- Exchange
- ADN Nasdaq
- TRAW NYSE
- Market Cap
- ADN 6.6M
- TRAW 7.8M
- IPO Year
- ADN N/A
- TRAW 2013
- Fundamental
- Price
- ADN $2.90
- TRAW $1.65
- Analyst Decision
- ADN
- TRAW
- Analyst Count
- ADN 0
- TRAW 0
- Target Price
- ADN N/A
- TRAW N/A
- AVG Volume (30 Days)
- ADN 23.4K
- TRAW 3.5M
- Earning Date
- ADN 12-27-2024
- TRAW 05-15-2025
- Dividend Yield
- ADN N/A
- TRAW N/A
- EPS Growth
- ADN N/A
- TRAW N/A
- EPS
- ADN N/A
- TRAW N/A
- Revenue
- ADN $3,276,000.00
- TRAW $227,000.00
- Revenue This Year
- ADN $2,232.99
- TRAW $3.81
- Revenue Next Year
- ADN $91.56
- TRAW $30.43
- P/E Ratio
- ADN N/A
- TRAW N/A
- Revenue Growth
- ADN 274.35
- TRAW 0.44
- 52 Week Low
- ADN $1.71
- TRAW $0.97
- 52 Week High
- ADN $8.79
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- ADN 55.41
- TRAW 54.15
- Support Level
- ADN $2.52
- TRAW $1.30
- Resistance Level
- ADN $2.74
- TRAW $2.58
- Average True Range (ATR)
- ADN 0.26
- TRAW 0.23
- MACD
- ADN 0.07
- TRAW 0.07
- Stochastic Oscillator
- ADN 84.51
- TRAW 34.04
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.